Clinical Trials Logo

Clinical Trial Summary

International, multicenter, observational, longitudinal monitoring study to investigate the prevalence of Alpha-Mannosidosis in participants at risk for Alpha-Mannosidosis.


Clinical Trial Description

Alpha-Mannosidosis is a lysosomal storage disorder of the Glycoprotein family of diseases and is closely related to Mucopolysaccharidoses.It is a rare inherited disorder that causes problems in many organs and tissues of the body. Affected individuals may have intellectual disability, distinctive facial features, and skeletal abnormalities. Characteristic facial features can include a large head, prominent forehead, low hairline, rounded eyebrows, large ears, flattened bridge of the nose, protruding jaw, widely spaced teeth, overgrown gums, and large tongue. The skeletal abnormalities that can occur in this disorder include reduced bone density (osteopenia), thickening of the bones at the top of the skull (calvaria), deformations of the bones in the spine (vertebrae), bowed legs or knock knees, and deterioration of the bones and joints. Affected individuals may also experience difficulty in coordinating movements (ataxia); muscle weakness (myopathy); delay in developing motor skills such as sitting and walking; speech impairments; increased risk of infections; enlargement of the liver and spleen (hepatosplenomegaly); a buildup of fluid in the brain (hydrocephalus); hearing loss; and a clouding of the lens of the eye (cataract). Alpha-Mannosidosis is estimated to occur in approximately 1 in 500,000 people worldwide. Mutations in the MAN2B1 gene cause Alpha-Mannosidosis. This gene provides instructions for making the enzyme alpha-mannosidase. Mutations in the MAN2B1 gene interfere with the ability of the alpha-mannosidase enzyme to perform its role in breaking down mannose-containing oligosaccharides. These oligosaccharides accumulate in the lysosomes and cause cells to malfunction and eventually die. Tissues and organs are damaged by the abnormal accumulation of oligosaccharides and the resulting cell death, leading to the characteristic features of Alpha-Mannosidosis. Modern methods, as DBS based mass-spectrometry give a great opportunity to - Simplify the diagnostic process - Simplify the logistics - Increases stability and reproducibility - Characterize specific metabolic alterations in the blood of affected patients that allow diagnosing the disease earlier, with a higher sensitivity and specificity. A more specific diagnosis that permits earlier detection of the disease, as well as assessment of the disease activity and progression, would also permit improved chances for earlier treatment of those patients suffering from the disease. It is the goal of this international, multicentre, epidemiological study to explore and analyse the prevalence of Alpha-Mannosidosis disease in a cohort of 1.000 patients with a suspicion of Alpha-Mannosidosis disease, based on the patient's clinical symptoms. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03651245
Study type Observational
Source CENTOGENE GmbH Rostock
Contact
Status Terminated
Phase
Start date August 20, 2018
Completion date May 30, 2022

See also
  Status Clinical Trial Phase
Completed NCT05086809 - Investigation of an Updated Bone-anchored Sound Processor N/A
Withdrawn NCT02890576 - Ambulatory Telemonitoring of People With Hearing Loss and Having a Cochlear Implant COCHLESURV
Completed NCT01256229 - Outcomes In Children With Developmental Delay And Deafness Phase 1
Recruiting NCT04795986 - First Clinical Evaluation of HEARO Robotic Cochlear Implantation Surgery in Austria
Recruiting NCT05867173 - Perceptual Consequences of Cochlear Implant Electrode-neuron Interfaces N/A
Completed NCT06104813 - Evaluation of Deaf Men's Knowledge About Sexual Health
Completed NCT04563884 - Validity of the French Version of Deafness Questionnaires for Children and Adolescents
Not yet recruiting NCT06088953 - EARLY DETECTION OF DEAFNESS IN A MEMORY CENTER N/A
Completed NCT03980808 - American Sign Language-Accessible Diabetes Education N/A
Completed NCT03694340 - Optimization of Cochlear Implant MAP-parameters in Children N/A
Terminated NCT01959152 - Evaluation of Hearing Preservation in Adults With Partial Low-Frequency Hearing Implanted With the HiFocus™ Mid-Scala Electrode N/A
Completed NCT02539901 - Development of a Deaf Child With a Cochlear Implant. N/A
Withdrawn NCT00604474 - Development of Auditory Skills in Young Deaf Children With Bilateral Cochlear Implants N/A
Completed NCT00511381 - Genetic Testing in Detection of Late-Onset Hearing Loss N/A
Terminated NCT03867058 - Tradeoff Between Spatial and Temporal Resolution
Completed NCT01109576 - Workshops for Veterans With Vision and Hearing Loss Phase 0
Completed NCT01400178 - Cochlear Implants in Post-lingually Children: Results After 10 Years N/A
Completed NCT04106063 - A New Speech, Spatial, and Qualities of Hearing Scale Short-Form for Deaf Children
Active, not recruiting NCT03352154 - Long Latency Auditory Evoked Potentials (P300) Outcomes in Patients With Unilateral Cochlear Implants N/A
Recruiting NCT04495660 - Restauration of the Auditory and Cognitive Functions in Cochlear Implanted Deaf Children in fNIRS N/A